Non-achievement of LDL-cholesterol targets in patients with diabetes at very-high cardiovascular risk receiving statin treatment: Incidence and risk factors

Cardiovascular diseases are the first cause of mortality in patients with diabetes, and LDL-cholesterol is a well-established cardiovascular risk factor. This study aimed to assess rate of LDL-cholesterol target attainment among patients with diabetes at very-high cardiovascular risk treated with st...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cardiology 2018-10, Vol.268, p.195-199
Main Authors: Breuker, Cyril, Clement, Florian, Mura, Thibault, Macioce, Valérie, Castet-Nicolas, Audrey, Audurier, Yohan, Boegner, Catherine, Morcrette, Emilie, Jalabert, Anne, Villiet, Maxime, Avignon, Antoine, Sultan, Ariane
Format: Article
Language:English
Subjects:
Aged
Biomarkers - blood
Cardiovascular Diseases - blood
Cardiovascular Diseases - drug therapy
Cardiovascular Diseases - epidemiology
Cardiovascular risk
Cholesterol, LDL - blood
Diabetes Mellitus - blood
Diabetes Mellitus - drug therapy
Diabetes Mellitus - epidemiology
Female
France - epidemiology
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Incidence
Life Sciences
Lipid-lowering therapy
Low-density lipoprotein cholesterol
Male
Middle Aged
Risk Factors
Treatment Outcome
Type 2 diabetes
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cardiovascular diseases are the first cause of mortality in patients with diabetes, and LDL-cholesterol is a well-established cardiovascular risk factor. This study aimed to assess rate of LDL-cholesterol target attainment among patients with diabetes at very-high cardiovascular risk treated with statins, and to identify predictive factors of non-attainment of target in this population. Patients were recruited in the Nutrition-Diabetes unit of Montpellier University Hospital, France, from 2014 to 2017. We included all consecutive patients with type 1 or type 2 diabetes receiving statin treatment and at very-high cardiovascular risk according to 2016 ESC guidelines, therefore having a LDL-cholesterol target of
ISSN:0167-5273
1874-1754
DOI:10.1016/j.ijcard.2018.04.068